339 related articles for article (PubMed ID: 31945018)
21. [Macrophage colony stimulating factor enhances non-small cell lung cancer invasion and metastasis by promoting macrophage M2 polarization].
Li YJ; Yang L; Wang LP; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):412-418. PubMed ID: 28635229
[No Abstract] [Full Text] [Related]
22. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
[TBL] [Abstract][Full Text] [Related]
23. The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy.
Kim SR; Chun SH; Kim JR; Kim SY; Seo JY; Jung CK; Gil BM; Kim JO; Ko YH; Woo IS; Shim BY; Hong SH; Kang JH
BMC Cancer; 2021 Jan; 21(1):19. PubMed ID: 33402127
[TBL] [Abstract][Full Text] [Related]
24. A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis.
Lei Q; Zhen S; Zhang L; Zhao Q; Yang L; Zhang Y
Cancer Immunol Immunother; 2024 Apr; 73(6):108. PubMed ID: 38642131
[TBL] [Abstract][Full Text] [Related]
25. Tumor hypoxia enhances Non-Small Cell Lung Cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling.
Zhang J; Cao J; Ma S; Dong R; Meng W; Ying M; Weng Q; Chen Z; Ma J; Fang Q; He Q; Yang B
Oncotarget; 2014 Oct; 5(20):9664-77. PubMed ID: 25313135
[TBL] [Abstract][Full Text] [Related]
26. Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy.
Dammeijer F; Lievense LA; Kaijen-Lambers ME; van Nimwegen M; Bezemer K; Hegmans JP; van Hall T; Hendriks RW; Aerts JG
Cancer Immunol Res; 2017 Jul; 5(7):535-546. PubMed ID: 28536100
[TBL] [Abstract][Full Text] [Related]
27. LncRNA-HOXC-AS2 regulates tumor-associated macrophage polarization through the STAT1/SOCS1 and STAT1/CIITA pathways to promote the progression of non-small cell lung cancer.
Yin C; Li J; Li S; Yang X; Lu Y; Wang C; Liu B
Cell Signal; 2024 Mar; 115():111031. PubMed ID: 38168631
[TBL] [Abstract][Full Text] [Related]
28. Macrophage-activating factor for cytotoxicity produced by a human T-cell hybridoma.
Higuchi M; Nakamura N; Tsuchiya SI; Kobayashi Y; Osawa T
Cell Immunol; 1984 Sep; 87(2):626-36. PubMed ID: 6205774
[TBL] [Abstract][Full Text] [Related]
29. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
30. PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer.
Shen C; Liu C; Zhang Z; Ping Y; Shao J; Tian Y; Yu W; Qin G; Liu S; Wang L; Zhang Y
Front Immunol; 2021; 12():680055. PubMed ID: 34194433
[TBL] [Abstract][Full Text] [Related]
31. TGR5 deficiency activates antitumor immunity in non-small cell lung cancer
Zhao L; Zhang H; Liu X; Xue S; Chen D; Zou J; Jiang H
Acta Pharm Sin B; 2022 Feb; 12(2):787-800. PubMed ID: 35256947
[TBL] [Abstract][Full Text] [Related]
32. Predicting the herbal medicine triggering innate anti-tumor immunity from a system pharmacology perspective.
Xiao Y; Zhang L; Zhu J; Zhang Y; Yang R; Yan J; Huang R; Zheng C; Xiao W; Huang C; Wang Y
Biomed Pharmacother; 2021 Nov; 143():112105. PubMed ID: 34560533
[TBL] [Abstract][Full Text] [Related]
33. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization.
Tan B; Shi X; Zhang J; Qin J; Zhang N; Ren H; Qian M; Siwko S; Carmon K; Liu Q; Han H; Du B; Liu M
Cancer Res; 2018 Sep; 78(17):4929-4942. PubMed ID: 29967265
[TBL] [Abstract][Full Text] [Related]
35. Blocking P2X7-Mediated Macrophage Polarization Overcomes Treatment Resistance in Lung Cancer.
Qin J; Zhang X; Tan B; Zhang S; Yin C; Xue Q; Zhang Z; Ren H; Chen J; Liu M; Qian M; Du B
Cancer Immunol Res; 2020 Nov; 8(11):1426-1439. PubMed ID: 32933967
[TBL] [Abstract][Full Text] [Related]
36. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
[TBL] [Abstract][Full Text] [Related]
37. Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages.
Mandula JK; Sierra-Mondragon RA; Jimenez RV; Chang D; Mohamed E; Chang S; Vazquez-Martinez JA; Cao Y; Anadon CM; Lee SB; Das S; Rocha-Munguba L; Pham VM; Li R; Tarhini AA; Furqan M; Dalton W; Churchman M; Moran-Segura CM; Nguyen J; Perez B; Kojetin DJ; Obermayer A; Yu X; Chen A; Shaw TI; Conejo-Garcia JR; Rodriguez PC
Immunity; 2024 May; 57(5):1124-1140.e9. PubMed ID: 38636522
[TBL] [Abstract][Full Text] [Related]
38. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
Hubert P; Roncarati P; Demoulin S; Pilard C; Ancion M; Reynders C; Lerho T; Bruyere D; Lebeau A; Radermecker C; Meunier M; Nokin MJ; Hendrick E; Peulen O; Delvenne P; Herfs M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33712445
[TBL] [Abstract][Full Text] [Related]
39. CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells.
Fortunato O; Belisario DC; Compagno M; Giovinazzo F; Bracci C; Pastorino U; Horenstein A; Malavasi F; Ferracini R; Scala S; Sozzi G; Roz L; Roato I; Bertolini G
Front Immunol; 2020; 11():02168. PubMed ID: 33123122
[TBL] [Abstract][Full Text] [Related]
40. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
